{
  "id": 12378586,
  "title": "Conexeu Sciences Advances Ten Minute Tissue™ Toward Planned FDA 510(k) Submission",
  "url": "https://urgent.news/2026/10/06/conexeu-sciences-advances-ten-minute-tissuetm-toward-planned-fda-510",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-06T12:54:20.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/conexeu-sciences-advances-ten-minute-tissue-toward-planned-fda-510k-submission"
  },
  "original_language": "en",
  "account": null,
  "summary": "Company advances manufacturing scale-up, regulatory testing and preclinical work supporting its planned FDA 510(k) submission in the first quarter of 2027. Multiple scaled-up batches of CXU™ material met predefined specifications, supporting both regulatory testing and future commercial production. RENO, Nev., Oct. 06, 2026 (GLOBE NEWSWIRE) — Conexeu Sciences Inc. (Nasdaq: CNXU) (“Conexeu” or the…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}